Overview
David Caneiro-Alonso practices in Brisbane, Australia. Mr. Caneiro-Alonso is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Nearsightedness, Retinopathy Pigmentary Mental Retardation, Pinguecula, and Late-Onset Retinal Degeneration.
His clinical research consists of co-authoring 114 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- NearsightednessMr. Caneiro-Alonso isDistinguished. Learn about Nearsightedness.
- Advanced
- Retinopathy Pigmentary Mental RetardationMr. Caneiro-Alonso isAdvanced. Learn about Retinopathy Pigmentary Mental Retardation.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Caneiro-Alonso isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- AstigmatismMr. Caneiro-Alonso isExperienced. Learn about Astigmatism.
- Cerebral HypoxiaMr. Caneiro-Alonso isExperienced. Learn about Cerebral Hypoxia.
- Diabetic RetinopathyMr. Caneiro-Alonso isExperienced. Learn about Diabetic Retinopathy.
- GlaucomaMr. Caneiro-Alonso isExperienced. Learn about Glaucoma.
- Late-Onset Retinal DegenerationMr. Caneiro-Alonso isExperienced. Learn about Late-Onset Retinal Degeneration.